Primary nasal tuberculosis during anti-tumour necrosis factor alpha treatment of a patient with rheumatoid arthritis

• Type: Article in International Scientific Journal
• Date: 2013

Authors

Ribeiro, S (Author) Other; Ferreira, B (Author) Other; Duarte R (Author) FMUP; Almeida, I (Author) Other; Carlos Vasconcelos (Author) ICBAS

Journal

Title: Scandinavian Journal of Infectious Diseases

Vol. 45

Pages: 957-960

ISSN: 0036-5548

Publisher: Taylor & Francis

Indexing

ISI Web of Knowledge - 2 Citations

Scopus - 2 Citations

Other information

Authenticus ID: P-008-H6N

DOI: 10.3109/00365548.2013.818246

Abstract (EN): Anti-tumour necrosis factor alpha (anti-TNF alpha) therapy is increasingly used in several inflammatory disease processes, including rheumatoid arthritis. However it has a significant potential for adverse events, such as reactivation of latent tuberculosis, which is frequently found in disseminated or extrapulmonary forms. We present a rare case of primary nasal tuberculosis within the context of anti-TNF alpha therapy for rheumatoid arthritis. To our knowledge, this is the first reported case of primary nasal tuberculosis in a patient with rheumatoid arthritis receiving anti-TNF alpha therapy.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 4